Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/14/21 09:59 | 9/14/21 | TBIO | Health | Drug | Pharmaceutical Preparations | Sanofi | I0 | T | P | 2,147,484 | 38.00 | 0 | 71,984 | 999% | 75,668 | D | |||||||||||||||
6/30/20 17:37 | 6/26/20 | TBIO | Health | BioPrd | Biological Products, (No Diag | Baupost Group Llc/ma | MA | T | P | 11,000 | 22.00 | 0 | 500 | 3 | 18,044 | I | |||||||||||||||
7/5/18 16:30 | 7/2/18 | TBIO | Health | BioPrd | Biological Products, (No Diag | Gallagher Brian M. Jr. | PA | D | P.d | 3,500 | 13.00 | 0 | 269 | 8 | 3,698 | I | |||||||||||||||
7/3/18 18:44 | 7/2/18 | TBIO | Health | BioPrd | Biological Products, (No Diag | Mrl Ventures Fund LLC | NJ | T | P.d | 325 | 13.00 | 0 | 25 | 1 | 1,874 | D | |||||||||||||||
7/3/18 17:59 | 7/2/18 | TBIO | Health | Drug | Pharmaceutical Preparations | Glaxosmithkline Plc | X0 | T | P.d | 3,500 | 13.00 | 0 | 269 | 8 | 3,698 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |